Steris Stock Forecast, Price & News

Steris' stock was trading at $145.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, STE shares have increased by 19.0% and is now trading at $172.82.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris.

Steris PLC (NYSE:STE) released its earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $0.98 by $0.33. The medical equipment provider had revenue of $668.90 million for the quarter, compared to analyst estimates of $643.38 million. Steris had a return on equity of 16.24% and a net margin of 13.69%. Steris's quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.23 earnings per share.
View Steris' earnings history.

Steris announced a quarterly dividend on Monday, August 3rd. Stockholders of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date of this dividend is Wednesday, August 26th. This is a positive change from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history.

4 analysts have issued 1 year price targets for Steris' shares. Their forecasts range from $170.00 to $175.00. On average, they expect Steris' share price to reach $172.50 in the next year. This suggests that the stock has a possible downside of 0.2%.
View analysts' price targets for Steris.

Steris saw a increase in short interest in August. As of August 31st, there was short interest totaling 1,140,000 shares, an increase of 24.0% from the August 15th total of 919,500 shares. Based on an average trading volume of 459,000 shares, the short-interest ratio is currently 2.5 days.
View Steris' Short Interest.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), Teleflex (TFX) and Insulet (PODD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Gilead Sciences (GILD), Home Depot (HD), Pfizer (PFE), AT&T (T), Mastercard (MA) and Medtronic (MDT).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $172.82.

Steris has a market capitalization of $14.70 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]